Literature DB >> 7488664

Intraperitoneal micro-organisms and the severity of peritonitis.

U Schoeffel1, E Jacobs, G Ruf, F Mierswa, B U von Specht, E H Farthmann.   

Abstract

OBJECTIVE: To find out if there was any correlation between the type or number of pathogenic bacteria in peritoneal exudate, the values of various prognostic scores, the inflammatory response, and the outcome, in patients with peritonitis.
DESIGN: Prospective open study.
SETTING: University hospital, Germany.
SUBJECTS: 51 Consecutive patients with secondary peritonitis.
INTERVENTIONS: Laparotomy within 12 hours of admission or within 8 hours of diagnosis in 9 patients with postoperative peritonitis. MAIN OUTCOME MEASURES: Correlation between the severity of the disease (APACHE II score, Septic Severity Score, Mannheim Peritonitis Index, Peritonitis Index Altona II, and outcome), the intraperitoneal and the systemic inflammatory response, intraperitoneal and systemic endotoxin concentrations, and type and number of micro-organisms grown from peritoneal fluid.
RESULTS: Intra-abdominal microbiological findings did not correlate with severity of illness judged by the scoring systems, the later incidence of infective complications, or the final outcome. The presence of intra-abdominal microbes was associated with signs of a systemic inflammatory response (median activation index 3 (range 1-3) compared with 2 (range 1-3)), the length of history (median 52 hours (range 3-72) compared with 16 hours (range 3-56), and local and systemic concentrations of endotoxin (peritoneal exudate: median 4800 EU/ml (range 0.06-136674) compared with 220 EU/ml (range 0.00-1800); plasma: median 0.05 EU/ml (range 0.00-1.32) compared with 0.04 EU/ml (range 0.00-0.13)). The sensitivity of the organisms to the antibiotics given (cefuroxime and metronidazole) did not influence the incidence of later infective complications or the outcome.
CONCLUSIONS: These results do not suggest micro-organisms invading the peritoneal cavity and respective antibiotic treatment to be major determinants of the clinical course of peritonitis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7488664

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  8 in total

Review 1.  The significance of endotoxin release in experimental and clinical sepsis in surgical patients--evidence for antibiotic-induced endotoxin release?

Authors:  R G Holzheimer
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

2.  The epidemiology of intra-abdominal flora in critically ill patients with secondary and tertiary abdominal sepsis.

Authors:  J de Ruiter; J Weel; E Manusama; W P Kingma; P H J van der Voort
Journal:  Infection       Date:  2009-12       Impact factor: 3.553

Review 3.  Epidemiology and pathophysiology of intraabdominal infections (IAI).

Authors:  E H Farthmann; U Schöffel
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

4.  Clinical and therapeutic features of nonpostoperative nosocomial intra-abdominal infections.

Authors:  Philippe Montravers; Annie Chalfine; Remy Gauzit; Alain Lepape; Jean Pierre Marmuse; Corinne Vouillot; Claude Martin
Journal:  Ann Surg       Date:  2004-03       Impact factor: 12.969

5.  A focus on intra-abdominal infections.

Authors:  Massimo Sartelli
Journal:  World J Emerg Surg       Date:  2010-03-19       Impact factor: 5.469

6.  Fungal Culture Positivity in Patients with Perforation Peritonitis.

Authors:  Neerja Jindal; Shilpa Arora; Sumeet Pathania
Journal:  J Clin Diagn Res       Date:  2015-06-01

7.  Complicated Intra-Abdominal Infections Observational European study (CIAO Study).

Authors:  Massimo Sartelli; Fausto Catena; Luca Ansaloni; Daniel V Lazzareschi; Korhan Taviloglu; Harry Van Goor; Pierluigi Viale; Ari Leppaniemi; Carlo De Werra
Journal:  World J Emerg Surg       Date:  2011-12-09       Impact factor: 5.469

8.  The Predictive Role of Procalcitonin On the Treatment of Intra-Abdominal Infections.

Authors:  Dafina Mahmutaj; Shaip Krasniqi; Bedri Braha; Dalip Limani; Burim Neziri
Journal:  Open Access Maced J Med Sci       Date:  2017-11-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.